…
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
AbbVie CDR (CAD Hedged) represents ownership of AbbVie Inc., a global biopharmaceutical company focused on therapies in immunology, oncology, aesthetics and neuroscience. Long-term growth drivers include portfolio diversification after legacy product transitions, ongoing clinical pipeline progress and recurring revenue from specialty medicines; the CAD-hedged CDR may benefit Canadian investors by reducing currency volatility while maintaining dividend exposure.
Principal risks include regulatory and patent-led revenue losses, clinical and pipeline setbacks, competitive pricing pressure and litigation exposure, together with hedging costs and depositary/credit structure risk.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ABBV AbbVie CDR (CAD Hedged) |
1.05 2.65% |
40.69 | 84.53 | 13.62 | 5.74 | 50.90 | 6.95 | 24.11 |
| AVGO Broadcom CDR (CAD Hedged) |
-0.24 1.95% |
12.35 | 12.44 | 5.73 | 4.54 | 3.78 | 28.65 | 52.40 |
| WMT Walmart CDR (CAD Hedged) |
2.30 4.43% |
54.19 | 45.06 | 41.67 | 1.38 | 9.84 | 1.51 | 23.16 |
| LLY Eli Lilly CDR (CAD Hedged) |
0.38 0.76% |
50.60 | 37.91 | 25.77 | 12.03 | 29.35 | 12.92 | 26.57 |
| JPM JPMorgan CDR (CAD Hedged) |
1.61 3.76% |
44.45 | 14.46 | 14.03 | 4.49 | 2.36 | 6.97 | - |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.